{"resourceType":"Observation","id":"08cdcf7b-3cba-5e51-9e4b-24d96d745d95","meta":{"versionId":"1","lastUpdated":"2022-05-24T16:17:00.568-04:00","source":"#NDBmHzGPgEjF7ypk","profile":["http://fhir.mimic.mit.edu/StructureDefinition/mimic-observation-micro-test"]},"identifier":[{"system":"http://fhir.mimic.mit.edu/identifier/observation-micro-test","value":"7546828-90132"}],"status":"final","category":[{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/observation-category","code":"laboratory"}]}],"code":{"coding":[{"system":"http://fhir.mimic.mit.edu/CodeSystem/microbiology-test","code":"90132","display":"LYME SEROLOGY"}]},"subject":{"reference":"Patient/74a2fd87-885b-5eca-9f8b-9141915dba51"},"valueString":"NO ANTIBODY TO B. BURGDORFERI DETECTED BY EIA.  Reference Range:  No antibody detected.  Negative results do not rule out B. burgdorferi infection.  Patients in early stages of infection or on antibiotic therapy may not produce  detectable levels of antibody.  Patients with clinical history and/or  symptoms suggestive of lyme disease should be retested in 2-3 weeks.  ","specimen":{"reference":"Specimen/8de7fdf5-2bcc-5b8c-b7c2-30d05e430389"}}